default author photo

Soo Kyung Kim

EuBiologics R&D Center

SCHOLARLY PAPERS

3

DOWNLOADS

264

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

A Multi-Center, Observer-Blind, Randomized, Phase 3 Study to Evaluate Safety, Non-Inferiority of Multi-Dose and Single-Dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) and Lot-to-Lot Consistency of the Immune Response to Multi-Dose Vial Formulation EuTCV in Healthy Participants in Kenya and Senegal

Number of pages: 19 Posted: 24 Jan 2025
Birahim Pierre Ndiaye, Lucy Koech, Laina Mercer, John J. Aponte, Badara Cisse, Faith Riziki, Winnie Keter, Djibril Wade, Siry Diye, Niles Eaton, Emily Locke, Mike Raine, Fred Cassels, Rahsan Erdem, Gamou Fall, Moussa Dia, Ndeye S. Bob, Yeong Ok Baik, Chankyu Lee, Youngran Park, Soo Kyung Kim, Howard Lee Her and Patricia Njuguna
Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI) - Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Institute for Disease Modeling, PATH, Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), PATH, PATH, PATH, PATH, PATH, University of Paris-Saclay - Institut Pasteur, Institut Pasteur de Dakar, Institut Pasteur de Dakar, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center and World Health Organization (WHO) - Global Malaria Programme
Downloads 133 (547,695)

Abstract:

Loading...

Africa, Kenya, Senegal, EuTCV, Typhoid, adults, children, infants, conjugate vaccine, safety, immunogenicity, intramuscular.

2.

A Phase II/III, Multicenter, Observer-Blinded, Randomized, Non-Inferiority and Safety, Study of Typhoid Conjugate Vaccine (EuTCV) Compared to Typbar-TCV ® in Healthy 6 Months-45 Years Aged Participants

Number of pages: 27 Posted: 24 Oct 2022
Seuk Keun Choi, Yeong Ok Baik, Youngjin Lee, Chankyu Lee, Soo Kyung Kim, Jooyoung Park, Meixiang Sun, DaYe Jung, Jin Young Jang, Tae Jun Yong, Jeong Woo Park, Sungho Jeong, Suwon Lim and Seung Hyun Han
EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, Seoul National University, Seoul National University, Seoul National University and Seoul National University
Downloads 93 (725,554)

Abstract:

Loading...

Typhoid conjugate vaccine, immunogenicity, phase II/III clinical trial, safety

3.

30-Minute Highly Multiplexed Vaxarray Immunoassay for Pneumococcal Vaccine Antigen Characterization

Number of pages: 26 Posted: 06 Oct 2022
Tianjing Hu, David F. Miller, Amber W. Taylor, Christine Riley, Caitlin McCormick, Keely N. Thomas, Rachel Y. Gao, Kathy L. Rowlen, Emilia B. Byrne, Pardeep Kumar, Soo Kyung Kim and Erica Dawson
InDevR Inc., InDevR Inc., InDevR Inc., InDevR Inc., InDevR Inc., InDevR Inc., InDevR Inc., InDevR Inc., Pfizer Inc., Pfizer Inc., EuBiologics R&D Center and InDevR Inc.
Downloads 38 (1,209,354)

Abstract:

Loading...

Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, CRM197, Identity Testing, Antigen Quantification, Vaccine Characterization, Multiplexed Immunoassay, Microarray, VaxArray